The Current perspectives on drug and chemical residue problems from FDA's Center for Veterinary Medicine

Authors

  • Richard H. Teske Deputy Director, Center for Veterinary Medicine, Food and Drug Administration, Rockville, Maryland

DOI:

https://doi.org/10.21423/bovine-vol0no25p18-21

Keywords:

cattle diseases, Chemicals, Drug residues, Drug therapy, Drugs, Somatotropin

Abstract

There is considerable focus on increasing the cooperation and communication between agencies at the Federal, State and local levels. As this becomes more of a reality it will become increasingly difficult for individuals with a history of producing animals, milk or eggs with violative residues to find markets that will accept them.

Paper presented at the 22nd AABP Convention, Kansas City, MO., Nov. 14-17, 1989

Cover image of the 25th Volume of the Bovine Practitioner: a photo of Indianapolis with the Hoosier Dome in the forefront.

Downloads

Published

1990-09-01

How to Cite

Teske, R. H. (1990). The Current perspectives on drug and chemical residue problems from FDA’s Center for Veterinary Medicine. The Bovine Practitioner, (25), 18–21. https://doi.org/10.21423/bovine-vol0no25p18-21

Issue

No. 25 (1990 September)

Section

Articles